litlas
Log inCreate account

Niklas Mattsson

Active 1999–2025

225
Papers
41,108
Citations
105
h-index
214
i10-index

Citations

Citations per year for Niklas Mattsson1967: 1 citations1988: 6 citations2000: 2 citations2001: 12 citations2002: 8 citations2003: 3 citations2004: 2 citations2005: 1 citations2006: 3 citations2007: 2 citations2008: 7 citations2009: 26 citations2010: 59 citations2011: 54 citations2012: 88 citations2013: 85 citations2014: 128 citations2015: 156 citations2016: 242 citations2017: 326 citations2018: 473 citations2019: 1,208 citations2020: 1,950 citations2021: 2,517 citations2022: 2,647 citations2023: 2,323 citations2024: 3,970 citations2025: 2,620 citations2026: 114 citations1968–1987: no citations, so these years are not shown1989–1999: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,068 citing papers, 21.1% of this breakdownUnited Kingdom: 1,976 citing papers, 10.3% of this breakdownSweden: 1,639 citing papers, 8.5% of this breakdownChina: 1,518 citing papers, 7.9% of this breakdownGermany: 996 citing papers, 5.2% of this breakdownNetherlands: 826 citing papers, 4.3% of this breakdownItaly: 779 citing papers, 4% of this breakdownSpain: 732 citing papers, 3.8% of this breakdownCanada: 704 citing papers, 3.7% of this breakdownFrance: 643 citing papers, 3.3% of this breakdownAustralia: 524 citing papers, 2.7% of this breakdownSwitzerland: 489 citing papers, 2.5% of this breakdown
0%21.1%Other 22.7%

Institutions

Fields

  • Medicine71.3%
  • Neuroscience12.6%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Computer Science1%
  • Immunology and Microbiology0.9%
  • Psychology0.7%
  • Other3.7%

Topics

  • Alzheimer's disease research and treatments17.7%
  • Dementia and Cognitive Impairment Research15.2%
  • Functional Brain Connectivity Studies3.2%
  • Neuroinflammation and Neurodegeneration Mechanisms2.8%
  • Parkinson's Disease Mechanisms and Treatments2.1%
  • Neurological Disease Mechanisms and Treatments2.1%
  • Other56.9%

Coauthors

All papers

Open in search
  1. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders

    Authors: Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E. Serrano, Antoine Leuzy, Niklas Mattsson, Olof Strandberg, Ruben Smith, Andrés Villegas, Diego Sepúlveda‐Falla, Xiyun Chai, Nicholas K. Proctor, Thomas G. Beach, Kaj Blennow, Jeffrey L. Dage, Eric M. Reiman, Oskar Hansson - JAMA 2020 cited by 1,546

  2. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

    Authors: Thomas K. Karikari, Tharick A. Pascoal, Nicholas J. Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Mira Chamoun, Mélissa Savard, Min Su Kang, Joseph Therriault, Michael Schöll, Gassan Massarweh, Jean-Paul Soucy, Kina Höglund, Gunnar Brinkmalm, Niklas Mattsson, Sebastian Palmqvist, Serge Gauthier, Erik Stomrud, Henrik Zetterberg, Oskar Hansson, Pedro Rosa‐Neto, Kaj Blennow - The Lancet Neurology 2020 cited by 1,360

  3. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia

    Authors: Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G. Beach, Geidy E. Serrano, Xiyun Chai, Nicholas K. Proctor, Udo Eichenlaub, Henrik Zetterberg, Kaj Blennow, Eric M. Reiman, Erik Stomrud, Jeffrey L. Dage, Oskar Hansson - Nature Medicine 2020 cited by 1,271

  4. Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests

    Authors: Nicolas R Barthélemy, Gemma Salvadó, Suzanne E. Schindler, Yingxin He, Shorena Janelidze, Lyduine E. Collij, Benjamin Saef, Rachel L. Henson, Charles D. Chen, Brian A. Gordon, Yan Li, Renaud La Joie, Tammie L.S. Benzinger, John C. Morris, Niklas Mattsson, Sebastian Palmqvist, Rik Ossenkoppele, Gil D. Rabinovici, Erik Stomrud, Randall J. Bateman, Oskar Hansson - Nature Medicine 2024 cited by 408

  5. Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

    Authors: Nicholas J. Ashton, Shorena Janelidze, Niklas Mattsson, Alexa Pichet Binette, Olof Strandberg, Wagner S. Brum, Thomas K. Karikari, Fernando González‐Ortiz, Guglielmo Di Molfetta, Francisco J. Meda, Erin M. Jonaitis, Rebecca L. Koscik, Karly Alex Cody, Tobey J. Betthauser, Yan Li, Eugeen Vanmechelen, Sebastian Palmqvist, Erik Stomrud, Randall J. Bateman, Henrik Zetterberg, Sterling C. Johnson, Kaj Blennow, Oskar Hansson - Nature Medicine 2022 cited by 431

  6. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

    Authors: Willemijn J. Jansen, Rik Ossenkoppele, Dirk L. Knol, Betty M. Tijms, Philip Scheltens, Frans R.J. Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea, M Alexander, Ina S. Almdahl, Steven E. Arnold, Inês Baldeiras, Henryk Barthel, Bart N.M. van Berckel, Kristen Bibeau, Kaj Blennow, David J. Brooks, Mark A. van Buchem, Vincent Camus, Enrica Cavedo, Kewei Chen, Gaël Chételat, Ann D. Cohen, Alexander Drzezga, Sebastiaan Engelborghs, Anne M. Fagan, Tormod Fladby, Adam Fleisher, Wiesje M. van der Flier, Lisa Ford, Stefan Förster, Juan Fortea, Nadia Foskett, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Giovanni B. Frisoni, Lutz Froelich, Tomasz Gabryelewicz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Mark Forrest Gordon, Timo Grimmer, Harald Hampel, Lucrezia Hausner, Sabine Hellwig, Sanna‐Kaisa Herukka, Helmut Hildebrandt, Lianna Ishihara, Adrian Ivanoiu, William J. Jagust, Peter Johannsen, Ramesh Kandimalla, Elisabeth Kapaki, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Sebastian Köhler, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Koen Van Laere, Susan Landau, Dong Young Lee, Mony J. de Leon, Viviana Lisetti, Alberto Lleó, Karine Madsen, Wolfgang Maier, Jan Marcusson, Niklas Mattsson, Alexandre de Mendonça, Olga Meulenbroek, Philipp T. Meyer, Mark A. Mintun, Vincent Mok, José Luís Molinuevo, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Stefan Van der Mussele, Duk L. Na, Andrew B. Newberg, Agneta Nordberg, Arto Nordlund, Gerald Novak, George P. Paraskevas, Lucilla Parnetti, Gayan Perera, Oliver Peters, Julius Popp, Sudesh Prabhakar, Gil D. Rabinovici, Inez H.G.B. Ramakers, Lorena Rami, Catarina R. Oliveira, Juha O. Rinne, Karen M. Rodrigue, Eloy Rodríguez‐Rodríguez and 29 more - JAMA 2015 cited by 1,635

  7. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

    Authors: Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom, Corrina Fonseca, Leonardo Iaccarino, Amy Wolf, Salvatore Spina, Isabel Elaine Allen, Yann Cobigo, Hilary W. Heuer, Lawren VandeVrede, Nicholas K. Proctor, Argentina Lario Lago, Suzanne L. Baker, Rajeev Sivasankaran, Agnieszka Kieloch, Arvind G. Kinhikar, Lili Yu, Marie‐Anne Valentin, Andreas Jeromin, Henrik Zetterberg, Oskar Hansson, Niklas Mattsson, Danielle Graham, Kaj Blennow, Joel H. Kramer, Lea T. Grinberg, William W. Seeley, Howard J. Rosen, Bradley F. Boeve, Bruce L. Miller, Charlotte E. Teunissen, Gil D. Rabinovici, Julio C. Rojas, Jeffrey L. Dage, Adam L. Boxer - The Lancet Neurology 2021 cited by 592

  8. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease

    Authors: Joana B Pereira, Shorena Janelidze, Ruben Smith, Niklas Mattsson, Sebastian Palmqvist, Charlotte E. Teunissen, Henrik Zetterberg, Erik Stomrud, Nicholas J. Ashton, Kaj Blennow, Oskar Hansson - Brain 2021 cited by 587

  9. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

    Authors: Jing Hua Zhao, David Stacey, Niclas Eriksson, Erin Macdonald-Dunlop, Åsa K. Hedman, Anette Kalnapenkis, Stefan Enroth, Domenico Cozzetto, Jonathan Digby‐Bell, Jonathan Marten, Lasse Folkersen, Christian Herder, Lina Jönsson, Sarah E. Bergen, Christian Gieger, Elise J. Needham, Praveen Surendran, Andres Metspalu, Lili Milani, Reedik Mägi, Mari Nelis, Georgi Hudjašov, Dirk S. Paul, Ozren Polašek, Barbara Thorand, Harald Grallert, Michael Roden, Urmo Võsa, Tõnu Esko, Caroline Hayward, Åsa Johansson, Ulf Gyllensten, Nick Powell, Oskar Hansson, Niklas Mattsson, Peter K. Joshi, John Danesh, Leonid Padyukov, Lars Klareskog, Mikael Landén, James F. Wilson, Agneta Siegbahn, Lars Wallentin, Anders Mälarstig, Adam S. Butterworth, James E. Peters - Nature Immunology 2023 cited by 729

  10. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

    Authors: Niklas Mattsson, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow, for the Alzheimer’s Disease Neuroimaging Initiative - JAMA Neurology 2017 cited by 1,081

  11. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures

    Authors: Sebastian Palmqvist, Pontus Tideman, Nicholas Cullen, Henrik Zetterberg, Kaj Blennow, the Alzheimer’s Disease Neuroimaging Initiative, Jeffrey L. Dage, Erik Stomrud, Shorena Janelidze, Niklas Mattsson, Oskar Hansson - Nature Medicine 2021 cited by 534

  12. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

    Authors: Niklas Mattsson, Nicholas Cullen, Ulf Andréasson, Henrik Zetterberg, Kaj Blennow - JAMA Neurology 2019 cited by 740

  13. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

    Authors: Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William J. Jagust, Oskar Hansson - Nature Communications 2017 cited by 947

  14. Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers

    Authors: Niklas Mattsson, Gemma Salvadó, Nicholas J. Ashton, Pontus Tideman, Erik Stomrud, Henrik Zetterberg, Rik Ossenkoppele, Tobey J. Betthauser, Karly Alex Cody, Erin M. Jonaitis, Rebecca Langhough, Sebastian Palmqvist, Kaj Blennow, Shorena Janelidze, Sterling C. Johnson, Oskar Hansson - JAMA Neurology 2023 cited by 295

  15. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

    Authors: Claire Bridel, Wessel N. van Wieringen, Henrik Zetterberg, Betty M. Tijms, Charlotte E. Teunissen, and the NFL Group, José C. Álvarez‐Cermeño, Ulf Andréasson, Markus Axelsson, David Bäckström, Aleš Bartoš, Maria Bjerke, Kaj Blennow, Adam L. Boxer, Lou Brundin, Joachim Burman, Tove Christensen, L Fialová, Lars Forsgren, Jette Lautrup Frederiksen, Magnus Gisslén, Elizabeth Gray, Martin Gunnarsson, Sara Hall, Oskar Hansson, Megan K. Herbert, Joel Jakobsson, Jan Jessen-Krut, Shorena Janelidze, Gudmundur Johannsson, Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kühle, Mikael Landén, Ville Leinonen, Giancarlo Logroscino, Ching‐Hua Lu, Jan Lycke, Nadia Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke Meeter, Sanjay R. Mehta, Signe Modvig, Tomas Olsson, Ross W. Paterson, Josué Pérez‐Santiago, Fredrik Piehl, Yolande A.L. Pijnenburg, Okko T. Pyykkö, Óskar Ragnarsson, Julio C. Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole Scherling, Jonathan M. Schott, Finn Sellebjerg, Isabella Laura Simone, Tobias Skillbäck, Morten Stilund, Peter Sundström, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R. Turner, John C. van Swieten, Mattias Vågberg, Marcel M. Verbeek, Luisa María Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelsø, Edward J. Wild - JAMA Neurology 2019 cited by 760

  16. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease

    Authors: Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, Shorena Janelidze, Yan Li, Yingxin He, Benjamin Saef, Charles D. Chen, Hong Jiang, Olof Strandberg, Alexa Pichet Binette, Sebastian Palmqvist, Chihiro Sato, Pallavi Sachdev, Akihiko Koyama, Brian A. Gordon, Tammie L.S. Benzinger, David M. Holtzman, John C. Morris, Niklas Mattsson, Erik Stomrud, Rik Ossenkoppele, Suzanne E. Schindler, Oskar Hansson, Randall J. Bateman - Nature Medicine 2023 cited by 250

  17. Blood‐based biomarkers for Alzheimer's disease

    Authors: Antoine Leuzy, Niklas Mattsson, Sebastian Palmqvist, Shorena Janelidze, Jeffrey L. Dage, Oskar Hansson - EMBO Molecular Medicine 2021 cited by 345

  18. Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care

    Authors: Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson, Suzanne E. Schindler, Ruben Smith, Rik Ossenkoppele, Susanna Calling, Tim West, Mark Monane, Philip B. Verghese, Joel B. Braunstein, Kaj Blennow, Shorena Janelidze, Erik Stomrud, Gemma Salvadó, Oskar Hansson - JAMA 2024 cited by 327

  19. Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease

    Authors: Shorena Janelidze, David Berron, Ruben Smith, Olof Strandberg, Nicholas K. Proctor, Jeffrey L. Dage, Erik Stomrud, Sebastian Palmqvist, Niklas Mattsson, Oskar Hansson - JAMA Neurology 2020 cited by 374

  20. Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads

    Authors: Gemma Salvadó, Rik Ossenkoppele, Nicholas J. Ashton, Thomas G. Beach, Geidy E. Serrano, Eric M. Reiman, Henrik Zetterberg, Niklas Mattsson, Shorena Janelidze, Kaj Blennow, Oskar Hansson - EMBO Molecular Medicine 2023 cited by 202

  21. Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

    Authors: Alexa Pichet Binette, Shorena Janelidze, Nicholas Cullen, Jeffrey L. Dage, Randall J. Bateman, Henrik Zetterberg, Kaj Blennow, Erik Stomrud, Niklas Mattsson, Oskar Hansson - Alzheimer s & Dementia 2022 cited by 219

  22. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

    Authors: Shorena Janelidze, Erik Stomrud, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson, David Airey, Nicholas K. Proctor, Xiyun Chai, Sergey Shcherbinin, John R. Sims, Gallen Triana‐Baltzer, Clara Theunis, Randy Slemmon, Marc Mercken, Hartmuth C. Kolb, Jeffrey L. Dage, Oskar Hansson - Nature Communications 2020 cited by 453

  23. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

    Authors: Claudia Cicognola, Shorena Janelidze, Joakim Hertze, Henrik Zetterberg, Kaj Blennow, Niklas Mattsson, Oskar Hansson - Alzheimer s Research & Therapy 2021 cited by 303

  24. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease

    Authors: Joel Simrén, Antoine Leuzy, Thomas K. Karikari, Abdul Hye, Andréa Lessa Benedet, Juan Lantero‐Rodriguez, Niklas Mattsson, Michael Schöll, Patrizia Mecocci, Bruno Vellas, Magda Tsolaki, Iwona Kłoszewska, Hilkka Soininen, Simon Lovestone, Dag Aarsland, Oskar Hansson, Pedro Rosa‐Neto, Eric Westman, Kaj Blennow, Henrik Zetterberg, Nicholas J. Ashton - Alzheimer s & Dementia 2021 cited by 351